Description
Provided is an anti-hTNF-alpha completely-humanized antibody. The antibody is applied to preparation of a drug or a pharmaceutical composition used for treating or preventing diseases with hTNF-alpha as a target spot, and preparation of a drug or a pharmaceutical composition used for treating or preventing autoimmune diseases. The anti-hTNF-alpha completely-humanized antibody has strong antigen binding affinity and significant neutralizing activity.
Target
TNF
Target Alias Names
Tumor Necrosis Factor, Tumor Necrosis Factor Ligand Superfamily Member 2, Cachectin, TNF-Alpha, TNFSF2, TNF-A, TNFA, Tumor Necrosis Factor (TNF Superfamily, Member 2), Tumor Necrosis Factor Ligand 1F
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression